ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Chandan Healthcare is pivoting from pharmacy trading to a high-margin diagnostic-led strategy. The company reported healthy revenue growth but is over-relying on capital-light franchise scaling to drive future profitability.
Chandan Healthcare reported strong Q1 FY27 results with 19.62% YoY revenue growth and 42.27% EBITDA growth, driven by expansion into 15 states and diversified B2C, B2B, and B2G segments.
Chandan Healthcare reported strong FY26 performance with Revenue of ₹280.67 Cr and PAT of ₹27.06 Cr, driven by network expansion and strategic PPP projects.
Chandan Healthcare reported robust FY26 results with 20.43% revenue growth, transitioning to a pan-India diagnostic model while scaling franchise and PPP projects.
Chandan Healthcare delivered robust FY26 growth, pivoting from a regional player to a pan-India diagnostic platform. Management remains aggressively optimistic about franchise scaling and government PPP projects despite high capital intensity.